Novel Combination Cancer Immunotherapy Summit 2024
Evvnt Promotion / evvnt
Archivio
15.10.2024 - 17.10.2024 Sheraton Mission Valley San Diego Hotel, 1433 Camino del Rio South, 92108 San Diego, California, USA
Time: 9:00 AM - 4:00 PM
Temi della conferenza
Welcome to the Novel Combination Cancer Immunotherapy Summit - Supercharging Immunotherapies with Rational Combinations of ICIS, OVs, Adoptive Cells and Beyond
Welcome to the Novel Combination Cancer Immunotherapy Summit - Supercharging Immunotherapies with Rational Combinations of ICIS, OVs, Adoptive Cells and Beyond
Professional congress organizer (PCO)
Hanson Wade Group
Hanson Wade Group
Annotazioni
URL:
Brochure: https://go.evvnt.com/2511263-2?pid=4832
Speakers: Michael Chisamore, Executive Director, Clinical Research, Merck and Co, Raj Ganesan, Executive Director, Oncology, Amgen , Yuanming Xu, Associate Director, Pfizer, and more
URL:
Brochure: https://go.evvnt.com/2511263-2?pid=4832
Speakers: Michael Chisamore, Executive Director, Clinical Research, Merck and Co, Raj Ganesan, Executive Director, Oncology, Amgen , Yuanming Xu, Associate Director, Pfizer, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2511263-1?pid=4832
Ms. Nell Sydenham
Oncologia
Lingua
Inglese
Inglese
Quote del Congresso
USD 1899.00 - USD 3997.00
USD 1899.00 - USD 3997.00
I partecipanti attesi
1000 - 1000
1000 - 1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
